Effects of Human papillomavirus type 16 E5 deletion mutants on epithelial morphology: Functional characterization of each transmembrane domain

Journal of General Virology

Volumn 91, Issue 2, 2010, Pages 521-530

  Barbaresi, Silvia ^a,b   Cortese, Marc S ^a   Quinn, Jean ^a   Ashrafi, G Hossein ^a,c   Graham, Sheila V ^a   Campo, M Saveria ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b ABBOTT DIAGNOSTICS   (Italy)

^c KINGSTON UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN 1; CYTOKERATIN 14; GELATINASE B; PROTEIN E5; UNCLASSIFIED DRUG; VIRUS PROTEIN; ONCOGENE PROTEIN E5, HUMAN PAPILLOMAVIRUS TYPE 16; ONCOPROTEIN;

ARTICLE; CELL CYCLE PROGRESSION; CELL DIFFERENTIATION; CELL INVASION; CELL STRUCTURE; CONTROLLED STUDY; DELETION MUTANT; ENZYME INDUCTION; ENZYME SYNTHESIS; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; HYDROPHOBICITY; KERATINOCYTE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; VIRAL GENETICS; VIRUS CELL INTERACTION; CELL MEMBRANE; CHEMISTRY; CYTOLOGY; EPITHELIUM CELL; GENE DELETION; GENETICS; METABOLISM; PAPILLOMAVIRUS INFECTION; PROTEIN TERTIARY STRUCTURE; VIROLOGY; VIRUS CELL TRANSFORMATION;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16;

CELL DIFFERENTIATION; CELL MEMBRANE; CELL TRANSFORMATION, VIRAL; EPITHELIAL CELLS; HUMAN PAPILLOMAVIRUS 16; HUMANS; KERATIN-14; KERATINOCYTES; MATRIX METALLOPROTEINASE 9; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRUS INFECTIONS; PROTEIN STRUCTURE, TERTIARY; SEQUENCE DELETION;

EID: 76249119825     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.016295-0     Document Type: Article

References (55)

1. Aasen, T., Hodgins, M. B., Edward, M. & Graham, S. V. (2003). The relationship between connexins, gap junctions, tissue architecture and tumour invasion, as studied in a novel in vitro model of HPV-16-associated cervical cancer progression. Oncogene 22, 7969-7980.
2. Adam, J. L., Briggs, M. W. & McCance, D. J. (2000). A mutagenic analysis of the E5 protein of human papillomavirus type 16 reveals that E5 binding to the vacuolar H+-ATPase is not sufficient for biological activity, using mammalian and yeast expression systems. Virology 272, 315-325.
3. Akgül, B., Pfefferle, R., Marcuzzi, G. P., Zigrino, P., Krieg, T., Pfister, H. & Mauch, C. (2006). Expression of matrix metalloproteinase (MMP)-2, MMP-9, MMP-13, and MT1-MMP in skin tumors of human papillomavirus type 8 transgenic mice. Exp Dermatol 15, 35-42.
4. Alazawi, W., Pett, M., Arch, B., Scott, L., Freeman, T., Stanley, M. A. & Coleman, N. (2002). Changes in cervical keratinocyte gene expression associated with integration of human papillomavirus 16. Cancer Res 62, 6959-6965.
5. Araibi, L. H. (2006). Down-regulation of MHC class I by papillomavirus E5 proteins. PhD thesis, University of Glasgow.
6. Ashrafi, G. H., Pitts, J. D., Faccini, A., McLean, P., O'Brien, V., Finbow, M. E. & Campo, M. S. (2000). Binding of bovine papillomavirus type 4 E5 to ductin (16K proteolipid), down-regulation of gap junction intercellular communication and full cell transformation are independent events. J Gen Virol 81, 689-694.
7. Ashrafi, G. H., Haghshenas, M. R., Marchetti, B., O'Brien, P. M. & Campo, M. S. (2005). The E5 protein of human papillomavirus type 16 selectively down-regulates surface HLA class. Int J Cancer 113, 276-283.
8. Ashrafi, G. H. H. M., Marchetti, B. & Campo, M. S. (2006). E5 protein of human papillomavirus 16 down-regulates HLA class I and interacts with the heavy chain via its first hydrophobic domain. Int J Cancer 119, 2105-2112.
9. Auvinen, E., Alonso, A. & Auvinen, P. (2004). Human papillomavirus type 16 E5 protein colocalizes with the antiapoptotic Bcl-2 protein. Arch Virol 149, 1745-1759.
10. Behren, A., Simon, C., Schwab, R. M., Loetzsch, E., Brodbeck, S., Huber, E., Stubenrauch, F., Zenner, H. P. & Iftner, T. (2005). Papillomavirus E2 protein induces expression of the matrix metalloproteinase-9 via the extracellular signal-regulated kinase/ activator protein-1 signaling pathway. Cancer Res 65, 11613-11621.
11. Björklund, M. & Koivunen, E. (2005). Gelatinase-mediated migration and invasion of cancer cells. Biochem Biophys Acta 1755, 37-69.
12. Borzacchiello, G., Mogavero, S., De Vita, G., Roperto, S., Della Salda, L. & Roperto, F. (2009). Activated platelet-derived growth factor beta receptor expression, PI3K-AKT pathway molecular analysis, and transforming signals in equine sarcoids. Vet Pathol 46, 589-597.
13. Boukamp, P., Petrussevska, R. T., Breitkreutz, D., Hornung, J., Markham, A. & Fusenig, N. E. (1988). Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J Cell Biol 106, 761-771.
14. Cavuslu, S., Starkey, W. G., Kell, B., Best, J. M. & Cason, J. (1996). Detection of human papillomavirus type 16 in microtitre plate based immuno-enzymatic assays: use to determine E5 gene expression in cervical carcinomas. Clin Diagn Virol 5, 215-218.
15. Chang, J. L., Tsao, Y. P., Liu, D. W., Huang, S. J., Lee, W. H. & Chen, S. L. (2001). The expression of HPV-16 E5 protein in squamous neoplastic changes in the uterine cervix. J Biomed Sci 8, 206-213.
16. Chen, S. L., Lin, Y. K., Li, L. Y., Tsao, Y. P., Lo, H. Y., Wang, W. B. & Tsai, T. C. (1996). E5 proteins of human papillomavirus types 11 and 16 transactivate the c-fos promoter through the NF1 binding element. J Virol 70, 8558-8563.
17. Chow, L. T. & Broker, T. R. (1997). In vitro experimental systems for HPV: epithelial raft cultures for investigations of viral reproduction and pathogenesis and for genetic analyses of viral proteins and regulatory sequences. Clin Dermatol 15, 217-227.
18. Clark, I. M., Swingler, T. E., Sampieri, C. L. & Edwards, D. R. (2008). The regulation of matrix metalloproteinases and their inhibitors. Int J Biochem Cell Biol 40, 1362-1378.
19. Conrad, M., Goldstein, D., Andresson, T. & Schlegel, R. (1994). The E5 protein of HPV-6, but not HPV-16, associates efficiently with cellular growth factor receptors. Virology 200, 796-800.
20. Cortese, M. S., Ashrafi, G. H. & Campo, M. S. (2009). All four dileucine motifs in the first hydrophobic domain of the E5 oncoprotein of human papillomavirus type 16 are essential for surface MHC class I down-regulation activity and E5 endomembrane localisation. Int J Cancer Oct 28 [Epub ahead of print].
21. Crusius, K., Auvinen, E. & Alonso, A. (1997). Enhancement of EGF-and PMA-mediated MAP kinase activation in cells expressing the human papillomavirus type 16 E5 protein. Oncogene 15, 1437-1444.
22. Crusius, K., Auvinen, E., Steuer, B., Gaissert, H. & Alonzo, A. (1998). The human papillomavirus type 16 E5 protein modulates ligand-dependent activation of the EGF receptor family in the human epithelial cell line HaCaT. Exp Cell Res 241, 78-83.
23. Deryugina, E. I. & Quigley, J. P. (2006). Matrix metalloproteinases and tumor metastasis. Cancer and Metastasis Reviews 25, 9-34.
24. Fehrmann, F., Klumpp, D. J. & Laimins, L. A. (2003). Human papillomavirus type 31 E5 protein supports cell cycle progression and activates late viral functions upon epithelial differentiation. J Virol 77, 2819-2831.
25. Genther, S. M., Sterling, S., Duensing, S., Munger, K., Sattler, C. & Lambert, P. F. (2003). Quantitative role of the human papillomavirus type 16 E5 gene during the productive stage of the viral life cycle. J Virol 77, 2832-2842.
26. Genther Williams, S. M., Disbrow, G. L., Schlegel, R., Lee, D., Threadgill, D. W. & Lambert, P. F. (2005). Requirement of epidermal growth factor receptor for hyperplasia induced by E5, a high-risk human papillomavirus oncogene. Cancer Res 65, 6534-6542.
27. Gerdes, J., Lemke, H., Baisch, H., Wacker, H. H., Schwab, U. & Stein, H. (1984). Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 133, 1710-1715.
28. Hu, L., Plafker, K., Vorozhko, V., Zuna, R. E., Hanigan, M. H., Gorbsky, G. J., Plafker, S. M., Angeletti, P. C. & Ceresa, B. P. (2009). Human papillomavirus 16 E5 induces bi-nucleated cell formation by cell-cell fusion. Virology 384, 125-134.
29. Kabsch, K., Mossadegh, N., Kohl, A., Komposch, G., Schenkel, J., Alonso, A. & Tomakidi, P. (2004). The HPV-16 E5 protein inhibits TRAIL- and FasL-mediated apoptosis in human keratinocyte raft cultures. Intervirology 47, 48-56.
30. Kell, B., Jewers, R. J., Cason, J., Pakarian, F., Kaye, J. N. & Best, J. M. (1994). Detection of E5 oncoprotein in human papillomavirus type 16-positive cervical scrapes using antibodies raised to synthetic peptides. J Gen Virol 75, 2451-2456.
31. Kim, S.-H., Juhnn, Y.-S., Kang, S., Park, S.-W., Sung, M.-W., Bang, Y.-J. & Song, Y.-S. (2006). Human papillomavirus 16 E5 up-regulates the expression of vascular endothelial growth factor through the activation of epidermal growth factor receptor, MEK/ERK1,2 and PI3K/Akt. Cell Mol Life Sci 63, 930-938.
32. Kim, S. H., Oh, J. M., No, J. H., Bang, Y. J., Juhnn, Y. S. & Song, Y. S. (2009). Involvement of NF-κB and AP-1 in COX-2 upregulation by human papillomavirus 16 E5 oncoprotein. Carcinogenesis 30, 753-757.
33. Krawczyk, E., Suprynowicz, F. A., Liu, X., Dai, Y., Hartmann, D. P., Hanover, J. & Schlegel, R. (2008). Koilocytosis: a cooperative interaction between the human papillomavirus E5 and E6 oncoproteins. Am J Pathol 173, 682-688.
34. Lehman, T. A., Modali, R., Boukamp, P., Stanek, J., Bennett, W. P., Welsh, J. A., Metcalf, R. A., Stampfer, M. R., Fusenig, N. & other authors (1993). p53 mutations in human immortalised cell lines. Carcinogenesis 14, 833-839.
35. Lewis, C., Baro, M. F., Marques, M., Grüner, M., Alonso, A. & Bravo, I. G. (2008). The first hydrophobic region of the HPV16 E5 protein determines protein cellular location and facilitates anchorage-independent growth. Virol J 5, 30-40.
36. Maufort, J. P., Genther Williams, S. M., Pitot, H. C. & Lambert, P. F. (2007). Human papillomavirus 16 E5 oncogene contributes to two stages of skin carcinogenesis. Cancer Res 67, 6106-6112.
37. Nakagawa, H., Inomoto, T. & Rustgi, A. K. (1997). A CACCC box-like cis regulatory element of the Epstein-Barr virus ED-L2 promoter interacts with a novel transcriptional factor in tissue-specific squamous epithelia. J Biol Chem 272, 16688-16699.
38. Narayan, G., Bourdon, V., Chaganti, S., Arias-Pulido, H., Nandula, S. V., Rao, P. H., Gissmann, L., Dürst, M., Schneider, A. & other authors (2007). Gene dosage alterations revealed by cDNA microarray analysis in cervical cancer: identification of candidate amplified and over-expressed genes. Genes Chromosomes Cancer 46, 373-384.
39. Oelze, I., Kartenbeck, J., Crusius, K. & Alonso, A. (1995). Human papillomavirus type 16 E5 protein affects cell-cell communication in an epithelial cell line. J Virol 69, 4489-4494.
40. Pilcher, B. K., Wang, M., Qin, X. J., Parks, W. C., Senior, R. M. & Welgus, H. G. (1999). Role of matrix metalloproteinases and their inhibition in cutaneous wound healing and allergic contact hypersensitivity. Ann N Y Acad Sci 878, 12-24.
41. Regan, J. A. & Laimins, L. A. (2008). Bap31 is a novel target of the human papillomavirus E5 protein. J Virol 82, 10042-10051.
42. Rodriguez, M. I., Finbow, M. E. & Alonso, A. (2000). Binding of human papillomavirus 16 E5 to the 16 kDa subunit c (proteolipid) of the vacuolar H+-ATPase can be dissociated from the E5-mediated epidermal growth factor receptor overactivation. Oncogene 19, 3727-3732.
43. Schapiro, F., Sparkowski, J., Adduci, A., Suprynowicz, F., Schlegel, R. & Grinstein, S. (2000). Golgi alkalinization by the papillomavirus E5 oncoprotein. J Cell Biol 148, 305-315.
44. Stanley, M. A., Browne, H. M., Appleby, M. & Minson, A. C. (1989). Properties of a non-tumorigenic human cervical keratinocyte cell line. Int J Cancer 43, 672-676.
45. Stoppler, M. C., Straight, S. W., Tsao, G., Schlegel, R. & McCance, D. J. (1996). The E5 gene of HPV-16 enhances keratinocyte immortalization by full-length DNA. Virology 223, 251-254.
46. Straight, S. W., Hinkle, P. M., Jewers, R. J. & McCance, D. J. (1993). The E5 oncoprotein of human papillomavirus type 16 transforms fibroblasts and effects the downregulation of the epidermal growth factor receptor in keratinocytes. J Virol 67, 4521-4532.
47. Straight, S. W., Herman, B. & McCance, D. J. (1995). The E5 oncoprotein of human papillomavirus type 16 inhibits the acidification of endosomes in human keratinocytes. J Virol 69, 3185-3192.
48. Suprynowicz, F. A., Campo, M. S. & Schlegel, R. (2006). Biological activities of papillomavirus E5 proteins. In Papillomavirus Research: From Natural History To Vaccines and Beyond, pp. 97-113. Edited by M. S. Campo. Norfolk, UK: Caister Academic Press.
49. Tomakidi, P., Cheng, H., Kohl, A., Komposch, G. & Alonso, A. (2000a). Connexin 43 expression is downregulated in raft cultures of human keratinocytes expressing the human papillomavirus type 16 E5 protein. Cell Tissue Res 301, 323-327.
50. Tomakidi, P., Cheng, H., Kohl, A., Komposch, G. & Alonso, A. (2000b). Modulation of the epidermal growth factor receptor by the human papillomavirus type 16 E5 protein in raft cultures of human keratinocytes. Eur J Cell Biol 79, 407-412.
51. Tsao, Y. P., Li, L. Y., Tsai, T. C. & Chen, S. L. (1996). Human papillomavirus type 11 and 16 E5 represses p21(WafI/SdiI/CipI) gene expression in fibroblasts and keratinocytes. J Virol 70, 7535-7539.
52. Wakisaka, N. & Pajano, J. S. (2003). Epstein-Barr virus induces invasion and metastasis factors. Anticancer Res 23, 2133-2138.
53. Yoshizaki, T., Sato, H., Furukawa, M. & Pagano, J. S. (1998). The expression of matrix metalloproteinase 9 is enhanced by Epstein-Barr virus latent membrane protein 1. Proc Natl Acad Sci U S A 95, 3621-3626.
54. Yuan, Z. Q., Nicolson, L., Marchetti, B., Gault, E. A., Campo, M. S. & Nasir, L. (2008). Transcriptional changes induced by bovine papillomavirus type 1 in equine fibroblasts. J Virol 82, 6481-6491.
55. Zhang, B., Li, P., Wang, E., Brahmi, Z., Dunn, K. W., Blum, J. S. & Roman, A. (2003). The E5 protein of human papillomavirus type 16 perturbs MHC class II antigen maturation in human foreskin keratinocytes treated with interferon-gamma. Virology 310, 100-108.